WHO Child Growth Standards Are Often Incorrectly Applied to Children Born Preterm in Epidemiologic Research

Nandita Perumal1, Michelle F Gaffey1, Diego G Bassani2

  • 1Centre for Global Child Health, Peter Gilgan Centre for Research and Learning, Hospital for Sick Children, Toronto, Canada; Department of Nutritional Sciences, University of Toronto, Toronto, Canada; and.

The Journal of Nutrition
|September 18, 2015
PubMed

Insights

Standard methods are lacking for analyzing growth data in preterm infants. Most studies include all infants, often using chronological age, but rarely address challenges or adjust for gestational age at birth.

Area of Science:

  • Epidemiology
  • Pediatric Growth Monitoring

Background:

  • No standard approach exists for analyzing postnatal anthropometric data in children born preterm (CBP).
  • Interpreting growth using WHO Growth Standards (WHO-GS) for CBP requires accounting for gestational age (GA) at birth.

Purpose of the Study:

  • To describe analytical approaches for accounting for GA at birth when applying WHO-GS to anthropometric data in epidemiologic studies including CBP.

Main Methods:

  • Scoping review of studies published 2006-2015 using WHO-GS with CBP.
  • Searched PubMed, Scopus, MEDLINE, Embase, and Web of Science for studies with data within 1 month of age.

Main Results:

  • 80% of 80 included studies used WHO-GS for all children, regardless of GA.
  • Of those including all children, 83% used chronological age, and 17% used corrected age.
  • Few studies explicitly addressed methodologic challenges or adjusted for GA in regression analyses.

Conclusions:

  • Researchers commonly apply WHO-GS to CBP, typically using chronological age.
  • Methodologic challenges in analyzing CBP data with WHO-GS are rarely addressed.
  • Further research is needed to establish acceptable methods for accounting for GA heterogeneity in epidemiologic studies.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
745
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
7.3K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
782
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
474